Keysight Introduces Automated and AI-Driven Testing to Optimize Experiences on 5G Smartphones
New application test automation method accelerates assessment of the quality of experience delivered by the…
New application test automation method accelerates assessment of the quality of experience delivered by the…
For many enterprises facing changing customer expectations and technologies, as-a-service offerings are the fastest way…
HUNTSVILLE, Ala.–(BUSINESS WIRE)–Hexagon’s Safety, Infrastructure & Geospatial division today announced the addition of artificial intelligence…
Australian and New Zealand businesses will be able to use conversational AI and customer intelligence…
Deep Franchise Mode Options, Cross-Platform Matchmaking and Social Features Enhance the Most Customizable Hockey Experience…
Local homebuyers and sellers can now work with full-service Redfin agents SEATTLE–(BUSINESS WIRE)–(NASDAQ: RDFN) —…
SAN JOSE, Calif.–(BUSINESS WIRE)–20 Korean tech companies specializing in various technologies such as AI &…
American Dental Association’s Former Executive Director Kathy O’Loughlin and Dental Innovator Ed Zuckerberg among venture…
This integrated solution enables brands to optimize 1,000+ organic search metrics with greater efficiency NEW…
NEW YORK–(BUSINESS WIRE)–Songclip, the world’s only patented music clip company, and Hipgnosis Songs Management (“Hipgnosis”),…
Customers Can Seamlessly Extend Nutanix Environment to Microsoft Azure SAN JOSE, Calif.–(BUSINESS WIRE)–#HCI—Nutanix (NASDAQ: NTNX),…
First ever phase 3 program of psilocybin therapy globally scheduled to begin in 2022 LONDON,…
WILMETTE, Ill., Oct. 12, 2022 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
Creators of the new AI-powered platform promise users the freedom to express themselves without fear…
SAN FRANCISCO–(BUSINESS WIRE)–SoFi Technologies, Inc. (NASDAQ: SOFI), the digital personal finance company, today announced plans…
The coveted accolade was presented at the 46th Annual IMPACT Awards held at the CBS…
Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission…
Clients were net buyers but returned to reducing exposure during the period as several catalysts…
Clinical and pre-clinical data from across the company’s portfolio will be featured in four oral…
PLEASANTON, Calif.–(BUSINESS WIRE)–Medallia, Inc., the global leader in customer and employee experience, today announced that…